32.6 F
New York
Saturday, March 6, 2021

Russia’s R-Pharm Signs Deal With AstraZeneca [NYSE: AZN] To Develop COVID-19 Vaccine

Must read

Fathom [NASDAQ: FTHM] Announces Purchase Of Real Estate Brokerage Business Of Red Barn

Fathom Holdings Inc. revealed that the company has purchased the residential real estate brokerage business of Red Barn Real Estate. Additionally, The Real...

Neilsen [NYSE: NLSN] Reports Completion Of The Divestiture Of Global Connect Business

Nielsen Holdings plc revealed that the company has finished the recently reported sale of NielsenIQ to associates of Advent International, in collaboration with...

Chipotle [NYSE: CMG] Collaborates With e.l.f [NYSE: ELF] To Launch Limited-Edition Makeup Collection

Chipotle and e.l.f. beauty is collaborating on March 10 to dispatch the limited edition e.l.f. x Chipotle collection. e.l.f's devotion to cruelty-free...

Jabil Healthcare [NYSE: JBL] Announces Strategic Partnership With E3D

Jabil Healthcare, a subsidiary of Jabil Inc. , revealed that the company has inked a partnership contract with E3D.  It is a worldwide drug...

Russian drugmaker R-Pharm has made a deal with a drug maker AstraZeneca to develop a coronavirus vaccine. It has disclosed on Friday that both the companies have signed the contract for the manufacturing of the COVID-19 vaccine which is being developed by the British pharmaceutical giant and Oxford University.

Canada, the US, and Britain earlier accused Russia that it is trying to steal the COVID-19 vaccine and treatment research. But after the deal, Russia’s wealth fund disclosed that Moscow has no need to steal information.

Shares of AstraZeneca soared 1.11% at $58.07 during the trading of Friday. It has a trading volume of 4.89 million as compared to the average volume of 5.41 million. In the past 52-weeks of trading, it has fluctuated between a low of 36.15 and a high of 58.84.

If we turn our focus on the profitability, it has reurn on investment (ROI) of 8.30%, return on equity (ROE) of 12.30% and return on assets (ROA) of 2.50%. This company has Gross Margin of 79.60%, and an Operating Margin of 12.10%, Profit Margin of 6.00%.

Alexey Repik, chairman of the R-Pharm Board said: “We have formalized the project in the area of signed agreements in the field of vaccine development and supply, developed by AstraZeneca and Oxford University.” R-Pharm specializes in research and development and manufacturing of high-tech medicines.

More articles

Latest article

XpresSpa Group [NASDAQ: XSPA] Inked An Agreement With The Port Of Seattle For A Covid-19 Testing Facility

XpresSpa Group, Inc. a wellbeing and health organization, reported that it has entered into an agreement with the Port of Seattle. The contract...

Zepp Health [NYSE: ZEPP] Announces Expanded Collaboration With Rouumtech

Zepp Health Corp. revealed that the company has expanded its collaboration with Rouumtech Co Ltd.  The contract initially expanded to reach to private label...

Netflix [NASDAQ: NFLX] Rolls Out Fast Laughs Featuring Comedy Bits

Netflix, In revealed through its newsroom the addition of a new feature on its mobile app. The Fast laugh is the new feature...

AT&T [NYSE: T] Enters Into A Contract To Divest Its Government Solution Business

AT&T announced that the company inked an agreement to divest its Government Solution Business (GSI). Tyto Athene will purchase the government solution including...

Sino-Global [NASDAQ: SINO] Announces The Execution Of Purchase Agreement Of 2783 Digital Currency Operating Server

Sino-Global Shipping America reported that the company is going to process the execution of the purchase agreement. The company purchased 2783 digital currency...

Commercial Vehicle Group [NASDAQ: CVGI] To Collaborate With Xos Inc

Commercial Vehicle Group revealed that the company entered into a collaboration with Xos, Inc. Furthermore, Xos is a leading commercial electric vehicle manufacturer....

Upland Software [NASDAQ: UPLD] Announces The Acquisition Of BlueVenn

Upland Software, Inc. revealed that the company has purchased BlueVenn. It is a cloud-based client data platform(CDP). With BlueVenn, Upland clients can now...

Columbus McKinnon [NASDAQ: CMCO] Inks An Agreement To Purchase Dorner

Columbus McKinnon Corporation today reported that the Company has executed an authoritative consent to secure Dorner Manufacturing Corporation. Dorer is an automation solution...